語系:
繁體中文
English
說明(常見問題)
圖資館首頁
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Bisphosphonates in bone diseasefrom the laboratory to the patient /
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Bisphosphonates in bone diseaseHerbert Fleisch.
其他題名:
from the laboratory to the patient /
作者:
Fleisch, Herbert.
出版者:
San Diego :Academic Press,c2000.
面頁冊數:
1 online resource (xii, 212 p.) :ill.
標題:
DiphosphonatesTherapeutic use.
電子資源:
http://www.sciencedirect.com/science/book/9780122603716
ISBN:
9780122603716
Bisphosphonates in bone diseasefrom the laboratory to the patient /
Fleisch, Herbert.
Bisphosphonates in bone disease
from the laboratory to the patient /[electronic resource] :Herbert Fleisch. - 4th ed. - San Diego :Academic Press,c2000. - 1 online resource (xii, 212 p.) :ill.
Includes bibliographical references and index.
Bone and Mineral Metabolism: -- Bone Physiology: -- Morphology. -- Composition of bone. -- Modeling and remodeling. -- Calcium homeostasis. -- Bone as an organ. -- Assessment of bone turnover. -- Bisphosphonates-Preclinical: -- Background to the pharmacological development: -- Chemistry. -- Actions. -- Physicochemical effects. -- Biological effects. -- Inhibition of bone resorption. -- Inhibition of mineralization. -- Pharmocokinetics: -- Intestinal absorption. -- Distribution. -- Renal clearance. -- Other modes of application. -- Animal toxicology: -- Acute toxicology. -- Nonacute toxicology. -- Bisphosphonates-clinical: -- Introduction. -- Paget's Disease: -- Definition. -- Epidemiology. -- Pathophysiology. -- Clinical manifestations. -- Treatment with drugs other than bisphosphonates. -- Treatment with bisphosphonates. -- Osteolytic tumor-induced bone disease: -- Definition. -- Pathophysiology. -- Clinical manifestations. -- Treatment with drugs other than bisphosphonates. -- Treatment with bisphosphonates. -- Non-tumor induced hypercalcemia: -- Definition. -- Pathophysiology. -- Clinical manifestations. -- Treatment with drugs other than bisphosphonates. -- Treatment with bisphosphonates. -- Osteoporosis: -- Definition. -- Epidemiology. -- Pathophysiology. -- Clinical manifestations. -- Treatment with drugs other than bisphosphonates. -- Treatment with bisphosphonates. -- Heterotopic calcification and ossification: -- Definition. -- Pathophysiology. -- Clinical manifestations. -- Treatment with drugs other than bisphosphonates. -- Treatment with bisphosphonates. -- Other diseases: -- Adverse events: -- Bisphosphonates in general. -- Individual bisphosphonates. -- Contraindications. -- Future prospects. -- Commercially available bisphosphonates: -- Index.
This book is an essential handbook on bisphosphonates, the most widely used new class of drugs for osteoporosis therapy. It reviews basic physiology in addition to the indications and adverse reactions of these drugs. Bisphosphonates in Bone Disease, 4E, discusses the compounds' chemistry, mechanisms of action, and animal toxicology before presenting a clinical picture of the diseases treated by bisphosphonates. The book provides a table listing the trade names of the commercially available bisphosphonates, registered indications, and the available forms for various countries. The revised Fourth Edition contains approximately 50% new material, including information on all of the latest drugs. * The revised fourth edition contains approximately 50% new material * Includes information on all the latest drugs.
ISBN: 9780122603716
Source: 89503:89503Elsevier Science & Technologyhttp://www.sciencedirect.comSubjects--Topical Terms:
233630
Diphosphonates
--Therapeutic use.Index Terms--Genre/Form:
214472
Electronic books.
LC Class. No.: RC930 / .F54 2000eb
Dewey Class. No.: 616.71061
National Library of Medicine Call No.: 2000 E-781
Bisphosphonates in bone diseasefrom the laboratory to the patient /
LDR
:04472cmm 2200493Ia 4500
001
342320
005
20120813074414.0
006
m d
007
cr cn|||||||||
008
120925s2000 caua ob 001 0 eng d
019
$a
212014137
$a
505068644
$a
648349421
$a
767670653
020
$a
9780122603716
020
$a
0122603710
020
$a
9780080528113 (electronic bk.)
020
$a
0080528112 (electronic bk.)
020
$z
0122603702 (pbk.)
020
$a
9780080573908 (electronic bk.)
020
$a
0080573908 (electronic bk.)
020
$z
9780122603709
029
1
$a
NZ1
$b
12432583
029
1
$a
DEBSZ
$b
315058838
029
1
$a
DEBBG
$b
BV039832661
035
$a
ocn162129426
037
$a
89503:89503
$b
Elsevier Science & Technology
$n
http://www.sciencedirect.com
040
$a
OPELS
$b
eng
$c
OPELS
$d
OCLCQ
$d
DEBSZ
$d
OCLCQ
$d
N$T
$d
YDXCP
$d
UBY
$d
IDEBK
$d
E7B
$d
OCLCQ
049
$a
NTYA
050
4
$a
RC930
$b
.F54 2000eb
060
4
$a
2000 E-781
060
4
$a
WE 225
$b
F596b 2000
072
7
$a
MED
$x
065000
$2
bisacsh
072
7
$a
HEA
$x
039100
$2
bisacsh
072
7
$a
MED
$x
083000
$2
bisacsh
082
0 4
$a
616.71061
$2
22
100
1
$a
Fleisch, Herbert.
$3
570687
245
1 0
$a
Bisphosphonates in bone disease
$h
[electronic resource] :
$b
from the laboratory to the patient /
$c
Herbert Fleisch.
250
$a
4th ed.
260
$a
San Diego :
$b
Academic Press,
$c
c2000.
300
$a
1 online resource (xii, 212 p.) :
$b
ill.
504
$a
Includes bibliographical references and index.
505
0
$a
Bone and Mineral Metabolism: -- Bone Physiology: -- Morphology. -- Composition of bone. -- Modeling and remodeling. -- Calcium homeostasis. -- Bone as an organ. -- Assessment of bone turnover. -- Bisphosphonates-Preclinical: -- Background to the pharmacological development: -- Chemistry. -- Actions. -- Physicochemical effects. -- Biological effects. -- Inhibition of bone resorption. -- Inhibition of mineralization. -- Pharmocokinetics: -- Intestinal absorption. -- Distribution. -- Renal clearance. -- Other modes of application. -- Animal toxicology: -- Acute toxicology. -- Nonacute toxicology. -- Bisphosphonates-clinical: -- Introduction. -- Paget's Disease: -- Definition. -- Epidemiology. -- Pathophysiology. -- Clinical manifestations. -- Treatment with drugs other than bisphosphonates. -- Treatment with bisphosphonates. -- Osteolytic tumor-induced bone disease: -- Definition. -- Pathophysiology. -- Clinical manifestations. -- Treatment with drugs other than bisphosphonates. -- Treatment with bisphosphonates. -- Non-tumor induced hypercalcemia: -- Definition. -- Pathophysiology. -- Clinical manifestations. -- Treatment with drugs other than bisphosphonates. -- Treatment with bisphosphonates. -- Osteoporosis: -- Definition. -- Epidemiology. -- Pathophysiology. -- Clinical manifestations. -- Treatment with drugs other than bisphosphonates. -- Treatment with bisphosphonates. -- Heterotopic calcification and ossification: -- Definition. -- Pathophysiology. -- Clinical manifestations. -- Treatment with drugs other than bisphosphonates. -- Treatment with bisphosphonates. -- Other diseases: -- Adverse events: -- Bisphosphonates in general. -- Individual bisphosphonates. -- Contraindications. -- Future prospects. -- Commercially available bisphosphonates: -- Index.
520
$a
This book is an essential handbook on bisphosphonates, the most widely used new class of drugs for osteoporosis therapy. It reviews basic physiology in addition to the indications and adverse reactions of these drugs. Bisphosphonates in Bone Disease, 4E, discusses the compounds' chemistry, mechanisms of action, and animal toxicology before presenting a clinical picture of the diseases treated by bisphosphonates. The book provides a table listing the trade names of the commercially available bisphosphonates, registered indications, and the available forms for various countries. The revised Fourth Edition contains approximately 50% new material, including information on all of the latest drugs. * The revised fourth edition contains approximately 50% new material * Includes information on all the latest drugs.
588
$a
Description based on print version record.
650
0
$a
Diphosphonates
$x
Therapeutic use.
$3
233630
650
0
$a
Bones
$x
Diseases
$x
Chemotherapy.
$3
570688
650
1 2
$a
Bone Diseases
$x
drug therapy.
$3
570689
650
1 2
$a
Bone Diseases
$x
metabolism.
$3
570690
650
2 2
$a
Diphosphonates
$x
pharmacology.
$3
570691
650
2 2
$a
Diphosphonates
$x
therapeutic use.
$3
570692
650
7
$a
MEDICAL
$x
Orthopedics.
$2
bisacsh
$3
570693
650
7
$a
HEALTH & FITNESS
$x
Diseases
$x
Musculoskeletal.
$2
bisacsh
$3
570694
650
7
$a
MEDICAL
$x
Rheumatology.
$2
bisacsh
$3
570695
650
0 7
$a
Diphosphonate.
$2
swd
$3
570696
650
0 7
$a
Knochenkrankheit.
$2
swd
$3
570697
655
4
$a
Electronic books.
$2
local.
$3
214472
776
0 8
$i
Print version:
$a
Fleisch, Herbert.
$t
Bisphosphonates in bone disease.
$b
4th ed.
$d
San Diego : Academic Press, c2000
$z
0122603710
$z
9780122603716
$w
(DLC) 00100337
$w
(OCoLC)43905464
856
4 0
$3
ScienceDirect
$u
http://www.sciencedirect.com/science/book/9780122603716
938
$a
YBP Library Services
$b
YANK
$n
2783740
938
$a
ebrary
$b
EBRY
$n
ebr10216738
筆 0 讀者評論
全部
電子館藏
館藏
1 筆 • 頁數 1 •
1
條碼號
館藏地
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
000000069422
電子館藏
1圖書
電子書
EB RC930 F54 2000
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
多媒體檔案
http://www.sciencedirect.com/science/book/9780122603716
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入